Mid-Atlantic Oncology Program Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
1990
NCT00002470
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1990

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

fluorouracil (efudex) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoid Tumor (Phase 2)

Gastrointestinal Neoplasms (Phase 2)

Malignant Carcinoid Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2